Related Experiment Video
Updated: Jun 6, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer
Min Wang1, Youji Hu, Michael D Amatangelo
1Department of Pathology, Drexel University College of Medicine, MS 435, 15th & Vine Streets, Philadelphia, PA 19102, USA.
Abstract:
We discovered that an inverse relationship exists in the expression of ras/c-myc and ribosomal protein RPS2 with pre-let-7a-1/let-7a/let-7f miRNA and prostate tumor cell malignancy. Nonmalignant IBC-10a cells expressed low levels of ras/RPS2 and elevated pre-let-7a-1/let-7a/let-7f miRNA, whereas the reverse occurred in malignant PCa-20a and PC-3ML cells. Stable transfection of IBC-10a cells with pBABE.ras and pBABE.RPS2 induced ras, c-myc, and RPS2 expression, whereas the levels of let-7a/let-7f miRNA dropped to near zero. Conversely, in pBABE.pre-let-7a-1 transfected PCa-20a and PC-3ML clones, let-7a/let-7f increased whereas ras, RPS2, and c-myc dropped greater than 5-fold. Electrophoretic mobility shift assays, antibody "supershift" assays and immunoprecipitation assays revealed that RPS2 specifically binds pre-let-7a-1 to block RNA processing. Immunoflourescent studies and Northern blots confirmed that RPS2 complexes with pre-let-7a-1 (i.e., in episomal structures) to block processing to let-7a/let-7f, indicating RPS2 may prevent let-7a miRNA expression to indirectly promote oncogene expression. Functional studies further showed that the colony-forming ability (CFA) and invasive activities of IBC-10a cells were significantly enhanced in pBABE-ras.IBC-10a and pBABE-RPS2-IBC-10a clones. Conversely, with the "knockdown" of ras and RPS2 in malignant PC-3ML cells (i.e., in pLKO.TRC.shRNA.ras.PC3-ML, pLKO.TRC.shRNA.RPS2.PC-3ML transfected cells), there was both a loss of these functions and a loss of tumorigenesis in SCID mice. Likewise, with the overexpression of let-7a/let-7f in pBABE.pre-let-7a-1.PC-3ML clones (and PCa-20a clones), CFAs, invasive activities in vitro, and tumorigenesis in vivo were significantly reduced. These results show for the first time that RPS2 blocks pre-let-7a-1 processing to enable ras and c-myc expression and the transformation of primary tumor cells.
Insights
Ribosomal protein RPS2 blocks let-7a miRNA processing, promoting oncogene expression and prostate tumor cell malignancy. Inhibiting RPS2 or enhancing let-7a miRNA reduces tumor growth and invasiveness.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Prostate cancer malignancy is linked to altered gene expression.
- MicroRNAs (miRNAs) play crucial roles in cancer development.
- The let-7 miRNA family is implicated in tumor suppression.
Purpose of the Study:
- To investigate the relationship between ribosomal protein RPS2, let-7 miRNA, and prostate tumor cell malignancy.
- To elucidate the mechanism by which RPS2 influences oncogene expression and tumor progression.
Main Methods:
- Stable transfection of cell lines with specific genes and miRNAs.
- Analysis of gene and miRNA expression levels (ras, c-myc, RPS2, let-7a/let-7f).
- Electrophoretic mobility shift assays, immunoprecipitation, immunofluorescence, and Northern blots.
- Functional assays including colony-forming ability, invasion assays, and in vivo tumorigenesis studies in SCID mice.
Main Results:
- An inverse relationship was observed between RPS2/oncogene expression and let-7 miRNA levels in prostate cancer cells.
- RPS2 directly binds to pre-let-7a-1, inhibiting its processing into mature let-7a/let-7f miRNA.
- Overexpression of RPS2 or ras/c-myc enhanced cell malignancy, while RPS2 knockdown or let-7a/let-7f overexpression reduced it.
- RPS2-mediated inhibition of let-7a processing promotes ras and c-myc expression, leading to cellular transformation.
Conclusions:
- RPS2 acts as a novel inhibitor of let-7a miRNA processing, thereby promoting oncogene expression and prostate tumor cell transformation.
- Targeting the RPS2-let-7a interaction may offer a therapeutic strategy for prostate cancer.
Related Concept Videos
MicroRNAs
MicroRNAs
Regulation of Expression at Multiple Steps
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Translational Regulation
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...

